» Articles » PMID: 38223361

Developing of Biotin-Thiamine Responsive Basal Ganglia Disease After Accidental Ingestion of Ethyl Alcohol: A Case Report

Overview
Journal J Epilepsy Res
Date 2024 Jan 15
PMID 38223361
Authors
Affiliations
Soon will be listed here.
Abstract

Biotin-thiamine-responsive basal ganglia disease (BTBGD) is a rare, inherited neurometabolic disorder caused by mutations in the gene and characterized by recurrent sub-acute episodes of encephalopathy that are often triggered by infections. Patients with BTBGD have classical neuroimaging findings and a dramatic response to high doses of thiamine. Herein, we report a 2 and a half-year-old Saudi girl presented with an acute onset of ataxia, slurred speech, and dysphagia, which was preceded by a history of accidental ingestion of around 20 mL of ethyl alcohol that is used in formulating perfumes 1 day earlier. Her older brother had a similar clinical presentation and was diagnosed with BTBGD. The patient was fully alert and spoke in full sentences with dysarthria. She was unable to walk unassisted. Investigation revealed a positive toxicity test for ethyl alcohol (10 mg/dL), and brain magnetic resonance imaging showed basal ganglia changes consistent with BTBGD. The dramatic response to high doses of thiamine suggested as a strong candidate gene, and Sanger sequencing revealed a homozygous (NM_025243.4): c.1264A>G (p.Thr422Ala) mutation. Patients with BTBGD should be cautious and aware of ethyl alcohol products, which can lead to a BTBGD crisis. The administration of a high dose of thiamin may be required in patients who have not responded to the recommended dose. Further clinical research is required to determine the optimal doses.

Citing Articles

Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives.

Karachaliou C, Livaniou E Int J Mol Sci. 2024; 25(12).

PMID: 38928282 PMC: 11203980. DOI: 10.3390/ijms25126578.

References
1.
Hoyumpa Jr A . Mechanisms of thiamin deficiency in chronic alcoholism. Am J Clin Nutr. 1980; 33(12):2750-61. DOI: 10.1093/ajcn/33.12.2750. View

2.
Kono S, Miyajima H, Yoshida K, Togawa A, Shirakawa K, Suzuki H . Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. N Engl J Med. 2009; 360(17):1792-4. DOI: 10.1056/NEJMc0809100. View

3.
Tallaksen C, Sande A, Bohmer T, Bell H, Karlsen J . Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol. 1993; 44(1):73-8. DOI: 10.1007/BF00315284. View

4.
Marce-Grau A, Marti-Sanchez L, Baide-Mairena H, Ortigoza-Escobar J, Perez-Duenas B . Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis. 2019; 42(4):581-597. DOI: 10.1002/jimd.12125. View

5.
Ortigoza-Escobar J, Molero-Luis M, Arias A, Oyarzabal A, Darin N, Serrano M . Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome. Brain. 2015; 139(Pt 1):31-8. DOI: 10.1093/brain/awv342. View